AlphaFold predicted structure
PPP2R5C · Q13362

Mean pLDDT
84.4/ 100
Confident
524 residues
Confidence breakdown
- Very high(≥ 90)69%
- Confident(70–90)11%
- Low(50–70)6%
- Very low(< 50)14%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
protein phosphatase 2 regulatory subunit B'gamma
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownHouge-Janssens syndrome 4
cancer
neurodegenerative disease
complex neurodevelopmental disorder
chronic myelogenous leukemia, BCR-ABL1 positive
vertebral column disorder
Intellectual disability
restless legs syndrome
Alzheimer disease
transient ischemic attack
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform
The B regulatory subunit might modulate substrate selectivity and catalytic activity, and might also direct the localization of the catalytic enzyme to a particular subcellular compartment. The PP2A-PPP2R5C holoenzyme may specifically dephosphorylate and activate TP53 and play a role in DNA damage-induced inhibition of cell proliferation. PP2A-PPP2R5C may also regulate the ERK signaling pathway through ERK dephosphorylation
PPP2R5C · Q13362

Mean pLDDT
84.4/ 100
Confident
524 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0